In-vivo Imaging Market Share

APAC Market Forecast

In-vivo imaging market in Asia Pacific is predicted to account for the largest share of 46% by 2037 impelled by the increasing spending in healthcare. This has led to the expansion of research & development activities in healthcare technology in the region, which might result in the development of more advanced In-vivo imaging techniques. According to estimates, the predicted cost of healthcare in India in 2020 was more than USD 190 billion.

North American Market Statistics

The North America In-vivo imaging market is estimated to be the second largest, during the forecast timeframe led by the presence of well-established healthcare infrastructure. The American economy's most important sector is the healthcare industry which focuses on cutting costs and enhancing patient outcomes. As a result, the availability of skilled medical professionals and advanced diagnostic techniques including for more precise diagnosis of diseases has increased in the region. This is expected to create huge demand for In-vivo imaging techniques.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of in-vivo imaging is estimated at USD 1.21 billion.

The in-vivo imaging market size was over USD 1.15 billion in 2024 and is poised to cross USD 2.64 billion by the end of 2037, growing at more than 6.6% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of cancer across the globe and the rising trend of precision medicine will drive the market growth.

Asia Pacific industry is set to account for largest revenue share 46% by 2037, impelled by increasing spending in healthcare in the region.

The major players in the market are Bruker, FUJIFILM VisualSonics Inc., Siemens, Miltenyi Biotec, CMR Naviscan, SCANCO Medical AG, Aspect Imaging Ltd., Mediso Ltd., LI-COR, Inc., MILabs B.V., MR Solutions.

In-vivo Imaging Market Share